The emerging treatment of this peptide represents a significant advance in the care of type 2 diabetes. Different to existing therapies, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – providing https://tirzepatide-peptide693431.estate-blog.com/40862829/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment